Table 1.
Patient tumor characteristics
| Variable | ||
|---|---|---|
| Mean age (range), years | 46 (21 - 89) | |
| Mean follow-up (range), years | 6.2 (0.1 - 11.6) | |
| Number of breast cancer deaths (%) | 31 (21.2) | |
| Breast cancer-specific 5-year survival (%) | 117 (80) | |
|
| ||
| Number (%) | ||
|
| ||
| ER status | Negative | 44 (30.1) |
| Positive | 102 (69.9) | |
| HER2 status | Negative | 123 (84.2) |
| Positive | 23 (15.8) | |
| Node status | Negative | 76 (52.1) |
| Positive | 70 (47.9) | |
| Tumor size | ≤20 mm | 49 (33.6) |
| >20 mm | 97 (66.4) | |
| Tumor grade | 1 | 19 (13.0) |
| 2 | 71 (48.6) | |
| 3 | 56 (38.4) | |
| Tumor Stage | I | 22 (15.1) |
| II | 80 (54.8) | |
| III | 44 (30.1) | |
| H3K27me3 | Low | 76 (52.1) |
| High | 70 (47.9) | |
| EZH2 | Low | 74 (50.7) |
| High | 72 (49.3) | |
| UTX | Low | 84 (57.5) |
| High | 62 (42.5) | |